IRIS Accounts Production v24.3.2.46 08811895 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false false true false Ordinary Shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh088118952022-12-31088118952023-12-31088118952023-01-012023-12-31088118952021-12-31088118952022-01-012022-12-31088118952022-12-3108811895ns15:EnglandWales2023-01-012023-12-3108811895ns14:PoundSterling2023-01-012023-12-3108811895ns10:Director12023-01-012023-12-3108811895ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3108811895ns10:SmallEntities2023-01-012023-12-3108811895ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3108811895ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3108811895ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3108811895ns10:FullAccounts2023-01-012023-12-310881189512023-01-012023-12-3108811895ns10:OrdinaryShareClass12023-01-012023-12-3108811895ns10:Director22023-01-012023-12-3108811895ns10:RegisteredOffice2023-01-012023-12-3108811895ns5:CurrentFinancialInstruments2023-12-3108811895ns5:CurrentFinancialInstruments2022-12-3108811895ns5:Non-currentFinancialInstruments2023-12-3108811895ns5:Non-currentFinancialInstruments2022-12-3108811895ns5:ShareCapital2023-12-3108811895ns5:ShareCapital2022-12-3108811895ns5:FurtherSpecificReserve2ComponentTotalEquity2023-12-3108811895ns5:FurtherSpecificReserve2ComponentTotalEquity2022-12-3108811895ns5:RetainedEarningsAccumulatedLosses2023-12-3108811895ns5:RetainedEarningsAccumulatedLosses2022-12-3108811895ns5:NetGoodwill2023-01-012023-12-3108811895ns5:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3108811895ns5:FurnitureFittings2023-01-012023-12-3108811895ns5:NetGoodwill2022-12-3108811895ns5:NetGoodwill2023-12-3108811895ns5:NetGoodwill2022-12-3108811895ns5:FurnitureFittings2022-12-3108811895ns5:ComputerEquipment2022-12-3108811895ns5:ComputerEquipment2023-01-012023-12-3108811895ns5:FurnitureFittings2023-12-3108811895ns5:ComputerEquipment2023-12-3108811895ns5:FurnitureFittings2022-12-3108811895ns5:ComputerEquipment2022-12-3108811895ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3108811895ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3108811895ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-12-3108811895ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2022-12-3108811895ns10:OrdinaryShareClass12023-12-3108811895ns5:RetainedEarningsAccumulatedLosses2022-12-3108811895ns5:FurtherSpecificReserve2ComponentTotalEquity2022-12-3108811895ns5:RetainedEarningsAccumulatedLosses2023-01-012023-12-31
REGISTERED NUMBER: 08811895 (England and Wales)



Financial Statements for the Year Ended 31 December 2023

for

Dna London Limited

Dna London Limited (Registered number: 08811895)

Contents of the Financial Statements
for the Year Ended 31 December 2023










Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Dna London Limited

Company Information
for the Year Ended 31 December 2023







DIRECTORS: Ms A Breda
N Mascitti





REGISTERED OFFICE: 76 Edgeley Lane
London
SW4 7UW





REGISTERED NUMBER: 08811895 (England and Wales)





ACCOUNTANTS: BBK Partnership
Chartered Accountants
& Statutory Auditors
1 Beauchamp Court
10 Victors Way
Barnet
Hertfordshire
EN5 5TZ

Dna London Limited (Registered number: 08811895)

Statement of Financial Position
31 December 2023

31.12.23 31.12.22
Notes £    £   
FIXED ASSETS
Intangible assets 4 20,250 27,000
Tangible assets 5 40,934 51,410
61,184 78,410

CURRENT ASSETS
Stocks 6 880 620
Debtors 7 820,103 660,273
Cash at bank and in hand 16,130 79,076
837,113 739,969
CREDITORS
Amounts falling due within one year 8 (286,096 ) (133,023 )
NET CURRENT ASSETS 551,017 606,946
TOTAL ASSETS LESS CURRENT
LIABILITIES

612,201

685,356

CREDITORS
Amounts falling due after more than one year 9 (288,377 ) (437,202 )
NET ASSETS 323,824 248,154

CAPITAL AND RESERVES
Called up share capital 11 100 100
Shareholders Fund 12 100,000 100,000
Retained earnings 12 223,724 148,054
SHAREHOLDERS' FUNDS 323,824 248,154

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Dna London Limited (Registered number: 08811895)

Statement of Financial Position - continued
31 December 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 March 2025 and were signed on its behalf by:





N Mascitti - Director


Dna London Limited (Registered number: 08811895)

Notes to the Financial Statements
for the Year Ended 31 December 2023


1. STATUTORY INFORMATION

Dna London Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on written down value

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


Dna London Limited (Registered number: 08811895)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 17 (2022 - 15 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 January 2023
and 31 December 2023 90,000
AMORTISATION
At 1 January 2023 63,000
Amortisation for year 6,750
At 31 December 2023 69,750
NET BOOK VALUE
At 31 December 2023 20,250
At 31 December 2022 27,000

Dna London Limited (Registered number: 08811895)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023


5. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 January 2023 150,602 9,261 159,863
Additions - 171 171
At 31 December 2023 150,602 9,432 160,034
DEPRECIATION
At 1 January 2023 105,626 2,827 108,453
Charge for year 8,995 1,652 10,647
At 31 December 2023 114,621 4,479 119,100
NET BOOK VALUE
At 31 December 2023 35,981 4,953 40,934
At 31 December 2022 44,976 6,434 51,410

6. STOCKS
31.12.23 31.12.22
£    £   
Stocks 880 620

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Tropix Ltd 439,006 424,072
Scian ltd 274,498 223,998
Intercompany - TRP23 Ltd 69,600 -
Directors' current accounts 36,999 12,203
820,103 660,273

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade creditors 44,555 (2 )
Tax 60,476 33,769
Social security and other taxes 32,607 13,675
VAT 104,404 41,527
Accrued expenses 44,054 44,054
286,096 133,023

Dna London Limited (Registered number: 08811895)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023


9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.12.23 31.12.22
£    £   
Bank loans (see note 10) 288,377 437,202

10. LOANS

An analysis of the maturity of loans is given below:

31.12.23 31.12.22
£    £   
Amounts falling due between one and two years:
Loans - 36,667

Amounts falling due between two and five years:
Other loans - 2-5 years 288,377 400,535

11. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.23 31.12.22
value: £    £   
100 Ordinary Shares £1 100 100

12. RESERVES
Retained Shareholders
earnings Fund Totals
£    £    £   

At 1 January 2023 148,054 100,000 248,054
Profit for the year 75,670 75,670
At 31 December 2023 223,724 100,000 323,724